Victoza: $1,175.56 Saxenda: $1,349.02 Tirzepatide: How it works and what it costs Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication
Compounded Semaglutide From Licensed Pharmacies vs
Retatrutide is a new investigational peptide that has gained attention in metabolic and obesity research
Tirzepatide (Mounjaro and Zepbound) Tirzepatide is a dual GIP/GLP-1 receptor agonist that has shown even greater weight loss in clinical trials compared to semaglutide
Medications such as Ozempic, Wegovy, Mounjaro, and Zepbound should be used in conjunction with lifestyle changes, including healthy eating and regular physical activity
Each formulation has been tested for stability under specific conditions, and the manufacturer or compounding pharmacy assigns storage guidelines based on those tests